Institutional investors control 11.27% of the outstanding shares in GSK. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2014, these large investors purchased a net $1.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABAL TRUST CO. Bought 310.9 Thousand shares of GlaxoSmithKline PLC
YELIN LAPIDOT MUTUAL FUND MANAGE... Bought 185.2 Thousand shares of GlaxoSmithKline PLC
AVIANCE CAPITAL MANAGEMENT LLC Bought 161.0 Thousand shares of GlaxoSmithKline PLC